How Multiomics Will Continue Improving Healthcare Outcomes in 2022

 How Multiomics Will Continue Improving Healthcare Outcomes in 2022

by Madhuri Hegde, PhD, FACMG – SVP and Chief Scientific Officer of Global Lab Services at PerkinElmer, Inc.

It’s hard to imagine today, but it once took 13 years and approximately $1B to sequence the human genome. Today – with the advent of next generation sequencing (NGS) and related technologies – this process takes just a few days, and there have been approximately 6,000 genes shown to be causative of ~7,000 disorders. With increasingly advanced technologies at their disposal, genomics laboratories are helping physicians marry genetic data with other information and resources to provide a more detailed view of an individual’s health profile. In fact, a more apt term to use these days is in place of genomics is multiomics.

In 2022, we will see increased interest and applications of multiomics in health care. This approach will continue to improve our understanding of the human genome, and how individual genes and their variants may make an individual more likely to be diagnosed with certain conditions or diseases. With broad, global applications of multiomics, public health stands to improve greatly—and here’s how.

Read more on Labcompare.